1,173 research outputs found
Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients
Purpose The purpose of this study was to assess the psychometric properties of the Satisfaction with Life Scale (SWLS), evaluate the measurement invariance with respect to sex, age, and tumor location, as well as analyze associations between life satisfaction and socio-demographic and clinical variables among individuals with resected, non-advanced cancer. Methods A confirmatory factor analysis was conducted to explore the dimensionality of the scale and test invariance across gender, age, and tumor localization in a prospective, multicenter cohort of 713 patients who completed the following scales: SWLS, Health-related Quality of Life Questionnaire (EORTC QLQ-C30), Brief Symptom Inventory (BSI-18). Results Confirmatory factor analysis results indicated that the SWLS is an essentially unidimensional instrument, providing accurate scores: both McDonald's omega and Cronbach's alpha estimates were 0.91. Strong measurement invariance was found to hold across gender, age, and tumor localization. Low satisfaction with life was associated with psychological symptoms (anxiety, depression, and somatization), and decreased quality of life (malfunction, symptoms, poor global QoL). Conclusion The SWLS is a reliable, valid satisfaction with life measurement among people with cancer and should be recommended as an indicator of psychological adjustment in oncological patients
The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables
Purpose The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients' emotional distress, and coping in subjects with resected, non-metastatic cancer. Methods 602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants' emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires. Results Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I-II (28 vs 18%). Conclusion Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients
Differences in coping strategies among young adults and the elderly with cancer
Background: Coping with cancer and the oncologist-patient relationship can vary depending on the patient's age. Our aim is to examine and compare young and elderly adults with non‐metastatic, resected cancer. Methods: Two groups of patients were selected, young ( 70) with a diagnosis of non‐metastatic, resected cancer requiring adjuvant chemotherapy from a pre‐exiting, national database (NEOCOPING Study). Epidemiological variables were collected and subjects' emotional responses, perceptions of the physician-patient relationship, support network, fears, and regret about the decision to receive chemotherapy were assessed with questionnaires validated in previous studies: Mini‐Mental Adjustment to Cancer, Brief Summary Inventory (18 items), European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire‐C30, Shared Decision‐Making Questionnaire‐Physician's version, Shared Decision‐Making Questionnaire‐Patient's version, and Informed Risk (physician and patient versions). Results: Data from 46 young and 46 elderly participants were collected. The most common neoplasms in both groups were breast (50%) and colorectal (22%). The younger adults had a higher level of education and were actively employed (72% vs. 7%). The leading coping strategy in the younger cohort was hope, and resignation among the elderly. Young adults sought more social support and the impact of diagnosis was more negative for them than for older individuals. No significant differences were detected in quality of life; both age groups demanded more time at their first visit with the doctor, while the older group exhibited greater satisfaction with shared decision‐making. At the end of adjuvant chemotherapy, neither age group regretted their decision to receive said treatment. Conclusion: Higher levels of education, greater demands of the labour market, and the advent of the age of information have entailed drastic changes in the physician-patient relationship paradigm. This is especially true in the younger cancer patient population, who require more information and active participation in decision‐making, can display more anxiety about their diagnosis, but also greater capacity to fight
Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy:Study protocol of a cluster randomized clinical trial (Multi-PAP project)
This study was funded by the Fondo de Investigaciones Sanitarias ISCIII (Grant Numbers PI15/00276, PI15/00572, PI15/00996), REDISSEC (Project Numbers RD12/0001/0012, RD16/0001/0005), and the European Regional Development Fund ("A way to build Europe").Background: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of partly preventable adverse effects, including mortality. The Ariadne principles describe a model of care based on a thorough assessment of diseases, treatments (and potential interactions), clinical status, context and preferences of patients with multimorbidity, with the aim of prioritizing and sharing realistic treatment goals that guide an individualized management. The aim of this study is to evaluate the effectiveness of a complex intervention that implements the Ariadne principles in a population of young-old patients with multimorbidity and polypharmacy. The intervention seeks to improve the appropriateness of prescribing in primary care (PC), as measured by the medication appropriateness index (MAI) score at 6 and 12months, as compared with usual care. Methods/Design: Design:pragmatic cluster randomized clinical trial. Unit of randomization: family physician (FP). Unit of analysis: patient. Scope: PC health centres in three autonomous communities: Aragon, Madrid, and Andalusia (Spain). Population: patients aged 65-74years with multimorbidity (≥3 chronic diseases) and polypharmacy (≥5 drugs prescribed in ≥3months). Sample size: n=400 (200 per study arm). Intervention: complex intervention based on the implementation of the Ariadne principles with two components: (1) FP training and (2) FP-patient interview. Outcomes: MAI score, health services use, quality of life (Euroqol 5D-5L), pharmacotherapy and adherence to treatment (Morisky-Green, Haynes-Sackett), and clinical and socio-demographic variables. Statistical analysis: primary outcome is the difference in MAI score between T0 and T1 and corresponding 95% confidence interval. Adjustment for confounding factors will be performed by multilevel analysis. All analyses will be carried out in accordance with the intention-to-treat principle. Discussion: It is essential to provide evidence concerning interventions on PC patients with polypharmacy and multimorbidity, conducted in the context of routine clinical practice, and involving young-old patients with significant potential for preventing negative health outcomes. Trial registration: Clinicaltrials.gov, NCT02866799Publisher PDFPeer reviewe
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism
Background Atrial fibrillation (AF) may exist before or occur early in the course of pulmonary embolism (PE). We determined the PE outcomes based on the presence and timing of AF. Methods and Results Using the data from a multicenter PE registry, we identified 3 groups: (1) those with preexisting AF, (2) patients with new AF within 2 days from acute PE (incident AF), and (3) patients without AF. We assessed the 90-day and 1-year risk of mortality and stroke in patients with AF, compared with those without AF (reference group). Among 16 497 patients with PE, 792 had preexisting AF. These patients had increased odds of 90-day all-cause (odds ratio [OR], 2.81; 95% CI, 2.33-3.38) and PE-related mortality (OR, 2.38; 95% CI, 1.37-4.14) and increased 1-year hazard for ischemic stroke (hazard ratio, 5.48; 95% CI, 3.10-9.69) compared with those without AF. After multivariable adjustment, preexisting AF was associated with significantly increased odds of all-cause mortality (OR, 1.91; 95% CI, 1.57-2.32) but not PE-related mortality (OR, 1.50; 95% CI, 0.85-2.66). Among 16 497 patients with PE, 445 developed new incident AF within 2 days of acute PE. Incident AF was associated with increased odds of 90-day all-cause (OR, 2.28; 95% CI, 1.75-2.97) and PE-related (OR, 3.64; 95% CI, 2.01-6.59) mortality but not stroke. Findings were similar in multivariable analyses. Conclusions In patients with acute symptomatic PE, both preexisting AF and incident AF predict adverse clinical outcomes. The type of adverse outcomes may differ depending on the timing of AF onset.info:eu-repo/semantics/publishedVersio
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER), "A way of making Europe".Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk. Imputed total C4, C4A, C4B, and HERV-K CN were analyzed in 26,633 individuals and validated in an independent cohort. Our results showed that higher C4 CN confers protection to SSc, and deviations from CN parity of C4A and C4B augmented risk. The protection contributed per copy of C4A and C4B differed by sex. Stronger protection was afforded by C4A in men and by C4B in women. C4 CN correlated well with its gene expression and serum protein levels, and less C4 was detected for both in SSc patients. Conditioned analysis suggests that C4 genetics strongly contributes to the SSc association within the major histocompatibility complex locus and highlights classical alleles and amino acid variants of HLA-DRB1 and HLA-DPB1 as C4-independent signals
Zoonosis, cambio climático y sociedad
La sociedad contemporánea se enfrenta a uno de los retos más grandes de la historia humana, el calentamiento global, mismo que acarrea enormes consecuencias, tales como los disturbios climáticos, así como los patrones de las enfermedades de origen animal transmisibles al hombre. Precisamente ante este escenario las instituciones educativas de nivel superior deben dar cumplimiento a su responsabilidad y ser las generadoras de alternativas de solución mediante el trabajo especializado de investigación; y para ello, la pesquisa científica es la mejor de las alternativas a nuestro alcance para comprender y encarar estos desafíos.Universidad Autónoma del Estado de México y Ediciones y Gráficos Eón, S.A. de C.V
New insights into the genetic etiology of Alzheimer's disease and related dementias
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele
(farsi - فارسی) 2023 تقویم علمی مکتب
El proyecto “Calendario Científico Escolar 2023” ha consistido en la elaboración de un calendario dirigido al alumnado de educación primaria y secundaria obligatoria. Cada día se ha recogido un aniversario científico o tecnológico como, por ejemplo, nacimientos de personas de estos ámbitos o conmemoraciones de hallazgos destacables. Además, el calendario se acompaña de una guía didáctica con orientaciones para el aprovechamiento educativo transversal del calendario en las clases, incluyendo actividades adaptadas a cada rango de edad y al alumnado con necesidades especiales. Se trata de la cuarta edición de este proyecto de divulgación científica.Proyecto FCT-21-17253 de la Fundación Española para la Ciencia y la Tecnología (FECYT); Agencia Estatal de Investigación (España); Ministerio de Ciencia e Innovación; Consejo Superior de Investigaciones Científicas; Universidad de León; Delegación del CSIC en Castilla y León; Instituto de Ganadería de Montaña (IGM, CSIC-ULE); Casa de la Ciència de Valencia (CSIC); Cátedra de Cultura Científica de la Universidad del País Vasco/ Euskal Herriko Unibertsitatea (UPV/EHU); People Help; University of California-Davis; Academia de la Llingua Asturiana; Federación Española de Esperanto; Teagasc; PuraVida Software; Universidad de Zaragoza; Casa Árabe; CSIC Delegació a Catalunya; CCULT.org; Museo Didáctico e Interactivo de Ciencias de la Vega Baja del Segura (MUDIC VBS-CV); Universidad Miguel Hernández; Unidade de Divulgación Científica e Cultural - Universidade da Coruña; Asociación Cultural Nogará Religada .Mujeres con Ciencia; Asociaţia Secular-Umanistă din România; Instituto Geológico y Minero de España (IGME); Centro de Biología Molecular Severo Ochoa (CSIC-UAM); Asociación Española para el Avance de la Ciencia (AEAC); Centro de Investigación del Cáncer (CIC, CSIC-USAL); Discapacitodos; Universitat de les Illes Balears (UIB); Comisión Mujeres y Ciencia de la Sociedad Geológica de España; Institut d’Investigació en Intel.ligéncia Artificial (IIIA-CSIC); Centre for Research in Agricultural Genomics (GRAG, CSIC-UAB-ICREA); Escuela de Estudios Hispano-americanos (CSIC); Institut Botànic de Barcelona (IIB, CSIC-Ajuntament Barcelona); Institut de Ciència de Materials de Barcelona (ICMAB, CSIC); Institut de Ciències del Mar (ICM, CSIC); PRISMA – Asociación para la diversidad afectivo-sexual y de género en ciencia, tecnología e innovación; Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA, CSIC); Círculo Escéptico; Civiencia; Universidad Autónoma de Madrid; Escuela de Estudios Árabes (CSIC); Evento Ciencia; Europa Laica; Universidad de Oviedo; Institut de Microelectrònica de Barcelona - Centre Nacional de Microelectrònica (IMB-CNM, CSIC); Centre d'Estudis Avançats de Blanes (CEAB, CSIC). ePeer reviewe
Scienca lerneja kalendaro 2023 (esperanto)
El proyecto “Calendario Científico Escolar 2023” ha consistido en la elaboración de un calendario dirigido al alumnado de educación primaria y secundaria obligatoria. Cada día se ha recogido un aniversario científico o tecnológico como, por ejemplo, nacimientos de personas de estos ámbitos o conmemoraciones de hallazgos destacables. Además, el calendario se acompaña de una guía didáctica con orientaciones para el aprovechamiento educativo transversal del calendario en las clases, incluyendo actividades adaptadas a cada rango de edad y al alumnado con necesidades especiales. Se trata de la cuarta edición de este proyecto de divulgación científica.Proyecto FCT-21-17253 de la Fundación Española para la Ciencia y la Tecnología (FECYT); Agencia Estatal de Investigación (España); Ministerio de Ciencia e Innovación; Consejo Superior de Investigaciones Científicas; Universidad de León; Delegación del CSIC en Castilla y León; Instituto de Ganadería de Montaña (IGM, CSIC-ULE); Casa de la Ciència de Valencia (CSIC); Cátedra de Cultura Científica de la Universidad del País Vasco/ Euskal Herriko Unibertsitatea (UPV/EHU); People Help; University of California-Davis; Academia de la Llingua Asturiana; Federación Española de Esperanto; Teagasc; PuraVida Software; Universidad de Zaragoza; Casa Árabe; CSIC Delegació a Catalunya; CCULT.org; Museo Didáctico e Interactivo de Ciencias de la Vega Baja del Segura (MUDIC VBS-CV); Universidad Miguel Hernández; Unidade de Divulgación Científica e Cultural - Universidade da Coruña; Asociación Cultural Nogará Religada.Mujeres con Ciencia; Asociaţia Secular-Umanistă din România; Instituto Geológico y Minero de España (IGME); Centro de Biología Molecular Severo Ochoa (CSIC-UAM); Asociación Española para el Avance de la Ciencia (AEAC); Centro de Investigación del Cáncer (CIC, CSIC-USAL); Discapacitodos; Universitat de les Illes Balears (UIB); Comisión Mujeres y Ciencia de la Sociedad Geológica de España; Institut d’Investigació en Intel.ligéncia Artificial (IIIA-CSIC); Centre for Research in Agricultural Genomics (GRAG, CSIC-UAB-ICREA); Escuela de Estudios Hispano-americanos (CSIC); Institut Botànic de Barcelona (IIB, CSIC-Ajuntament Barcelona); Institut de Ciència de Materials de Barcelona (ICMAB, CSIC); Institut de Ciències del Mar (ICM, CSIC); PRISMA – Asociación para la diversidad afectivo-sexual y de género en ciencia, tecnología e innovación; Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA, CSIC); Círculo Escéptico; Civiencia; Universidad Autónoma de Madrid; Escuela de Estudios Árabes (CSIC); Evento Ciencia; Europa Laica; Universidad de Oviedo; Institut de Microelectrònica de Barcelona - Centre Nacional de Microelectrònica (IMB-CNM, CSIC); Centre d'Estudis Avançats de Blanes (CEAB, CSIC).Peer reviewe
- …